Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Advaxis Inc (NASDAQ:ADXS)

7.13
Delayed Data
As of Jul 20
 -0.11 / -1.52%
Today’s Change
5.70
Today|||52-Week Range
16.30
-0.42%
Year-to-Date
No recent news for Advaxis Inc.

Today’s Trading

Previous close7.24
Today’s open7.26
Day’s range7.10 - 7.42
Volume423,866
Average volume (3 months)644,237
Market cap$293.0M
Dividend yield--
Data as of 4:00pm ET, 07/20/2017

Growth & Valuation

Earnings growth (last year)-23.81%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales71.69
Price/Book2.43

Competitors

 Today’s
change
Today’s
% change
SNDXSyndax Pharmaceutica...-0.03-0.23%
AVEOAveo Pharmaceuticals...-0.11-4.18%
TTPHTetraphase Pharmaceu...+0.46+6.21%
PETXAratana Therapeutics...+0.01+0.14%
Data as of 4:00pm ET, 07/20/2017

Financials

Next reporting dateSeptember 11, 2017
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$4.0M
Annual profit (last year)-$73.6M
Net profit margin-1,841.27%

Profile

Sector
Health Technology
Industry
Biotechnology
EVP, Chief Executive &
Business Officer
Anthony A. Lombardo
Chief Operating Officer &
Senior Vice President
Christopher M. Duke
Corporate headquarters
Princeton, New Jersey

Forecasts